Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hector W. Alila"'
Autor:
Anil K. Sood, Robert L. Coleman, Sanghoon Lee, Hector W. Alila, Carola Leuschner, Anca Chelariu-Raicu, Shaolin Ma, Mark Seungwook Kim
Supplementary data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73996b6b420ed69bf7316758d4eb8ad0
https://doi.org/10.1158/1535-7163.22518862
https://doi.org/10.1158/1535-7163.22518862
Autor:
Anil K. Sood, Robert L. Coleman, Sanghoon Lee, Hector W. Alila, Carola Leuschner, Anca Chelariu-Raicu, Shaolin Ma, Mark Seungwook Kim
Here, we examined the role of EP-100 [luteinizing hormone-releasing hormone (LHRH) ligand joined to a lytic peptide], improving the efficacy of immune checkpoint blockade. LHRH-R–positive murine ovarian cancer cells (ID8, IG10, IF5, and 2C12) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4317e65c478a1f219dcda2e9f0d677f0
https://doi.org/10.1158/1535-7163.c.6542158
https://doi.org/10.1158/1535-7163.c.6542158
Publikováno v:
Human Gene Therapy. 9:2039-2047
Current surgical strategies for the treatment of laryngeal paralysis are limited by the muscle atrophy associated with denervation. Moreover, attempts at reinnervation have not effected significant change in surgical outcome. To address this clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b9e3e14b8d01d038c204d46b77c7dd2
https://doi.org/10.1089/hum.1998.9.14-2039
https://doi.org/10.1089/hum.1998.9.14-2039
Autor:
Mark Logan, Alain Rolland, James T. Sparrow, Cynthia Li, Mei Shi, Louis C. Smith, John G. Duguid, Eric Tomlinson, Hector W. Alila
Publikováno v:
Biophysical Journal. 74(6):2802-2814
Novel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic peptide (GLFEALLELLESLWELLLEA), have been formulated with DNA plasmids to create peptide-based gene delivery systems. The carrier peptides are used to condense pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c876012bbe0f5823405be6526ae74b2
Autor:
Khursheed Anwer, Arun Singhal, Martha French, Jijun Wang, Russell J. Mumper, Mei Shi, Belinda Proctor, Hector W. Alila, Alain Rolland, Qingsong Liu, Wei Chen, Susanne Muller
Publikováno v:
Human gene therapy. 9(5)
A muscle-specific gene medicine is described that provides for long-term secretion of biologically active human growth hormone (hGH) from skeletal muscle into the systemic circulation. The hGH gene medicine is composed of a muscle-specific hGH plasmi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6d699772d1e5892bea40f9f14be2ba
https://pubmed.ncbi.nlm.nih.gov/9551614
https://pubmed.ncbi.nlm.nih.gov/9551614
Autor:
Jijun Wang, Russ Mumper, Martha French, Dalal Oubari, Alain Rolland, Hiroaki Nitta, Scott Long, Khursheed Anwer, Hector W. Alila, Jeff Nordstrom, Qingsong Liu, Todd Meyer, Michael E. Coleman
Publikováno v:
Human gene therapy. 8(15)
Recent evidence has shown that insulin-like growth factor-I (IGF-I) plays an important role in the development, maintenance, and regeneration of peripheral nerves and skeletal muscle. IGF-I offers the potential to treat neuromuscular diseases in huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02bee5e81257649630f2a46606b0970
https://pubmed.ncbi.nlm.nih.gov/9358028
https://pubmed.ncbi.nlm.nih.gov/9358028
Publikováno v:
Fertility and Sterility. 47:947-955
We have examined the effects of prolactin (PRL) on progesterone (P) and estradiol (E2) synthesis by cells obtained from human corpora lutea of early and midluteal phases. The cells were cultured in the presence or absence of low (200 mIU/l) or high l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a32bde612035e6b4bd7113527d5c8b
https://doi.org/10.1016/s0015-0282(16)59228-0
https://doi.org/10.1016/s0015-0282(16)59228-0
Publikováno v:
BioScience. Dec1983, Vol. 33 Issue 11, p727-730. 4p.
Publikováno v:
Archives of Otolaryngology - Head & Neck Surgery; Mar1999, Vol. 125 Issue 3, p274, 6p, 3 Black and White Photographs
Publikováno v:
Cancer Research. 73:978-978
EP-100, a targeted anti-cancer drug comprised of a lytic peptide fused to Luteinizing Hormone Releasing Hormone (LHRH), is in Phase 2 clinical trial in tumors that over-express LHRH receptors in combination with paclitaxel. It kills cancer cells by m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6fbb1129c03b4dda702219c18ebd637
https://doi.org/10.1158/1538-7445.am2013-978
https://doi.org/10.1158/1538-7445.am2013-978